CareLit · DOI-Nachweis · Klinische Pädiatrie
Neurotrophin Receptor TrkC Predicts Good Clinical Outcome in Medulloblastoma and Other Primitive Neuroectodermal Brain Tumors
DOI 10.1055/s-2000-10044
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM. A. Grotzer, A. J. Janss, P. C. Phillips, J. Q. Trojanowski
ZeitschriftKlinische Pädiatrie
Ausgabe04/2000
Jahrgang / SeitenJg. 212 · S. 196-199
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract. BACKGROUND: Neurotrophins and their cognate receptors TrkA, TrkB and TrkC regulate proliferation, differentiation and death of neuronal progenitor cells and may be implicated in the progression of medulloblastoma and other primitive neuroectodermal brain tumors (PNET). These common childhood brain tumors are composed of morphologically undifferentiated cells that have important similarities to neuroectoder…
Zitieren
Zitierempfehlung
M. A. Grotzer, A. J. Janss, P. C. Phillips, J. Q. Trojanowski (2000) Neurotrophin Receptor TrkC Predicts Good Clinical Outcome in Medulloblastoma and Other Primitive Neuroectodermal Brain Tumors. Klinische Pädiatrie, 212 (04), 196-199. https://doi.org/10.1055/s-2000-10044
Mit CareLit weiterarbeiten